1.
Budiarti N, Ikawati Z, Nurrochmad A, Arief TA. Understanding the Safety Profile of Imatinib in Asian Chronic Myeloid Leukemia Patients: A Systematic Review. JINTO [Internet]. 2026 Mar. 13 [cited 2026 Mar. 14];12(1):2-14. Available from: https://e-journal.unmas.ac.id/index.php/Medicamento/article/view/13296